Categories
FEATURED Markets

Global Blood Therapeutics, Inc. (NASDAQ:GBT) Stock Slumped 6.05% in Pre-market

Global Blood Therapeutics, Inc. (NASDAQ:GBT) announced an agreement to sell approximately $200.0 million in shares of its common stock in a registered underwritten public offering.  In addition, GBT has granted the underwriter a 30-day option to purchase up to approximately $30.0 million in shares of its common stock.

Global Blood Therapeutics, Inc. (NASDAQ:GBT) shares fell -1.36% to finally closed at $62.43 in last active session. 

GBT’s distance from 20 day simple moving average is 6.10% and distance from 50-Day simple moving average is 8.30%.

Analyst’s mean target price for GBT is $91.23 while analysts mean recommendation is 1.70. Stock value has moved between $30.16 – 65.03 in last one year. Stock has got OUTPERFORM rating from 6 of Thomson Reuters analysts, 2 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for GBT is $91.23 while analysts mean recommendation is 1.70. 

Global Blood Therapeutics, Inc. (NASDAQ:GBT) yearly performance is 48.47%. Annual EPS Growth of past 5 years is -30.20%. The current share price indicates that stock is -3.79% away from its one year high and is moving 107.06% ahead of its 52-week low. 



On 25 June 2018, General Mills, Inc. (NYSE:GIS) shares climbs 0.06% and ultimately finalized to $53.70 in last traded day. Stock has got OUTPERFORM rating from 0 of Thomson Reuters analysts, 12 given HOLD rating to the stock and 2 given UNDERPERFORM rating. Analyst’s mean target price for GIS is $50.47 while analysts mean recommendation is 2.80. 



At the movement Hecla Mining Company (NYSE:HL) is under coverage by number of analysts. Buy rating has been given by 0 analysts to the company stock whereas 5 given UNDERPERFORM rating to stock and 5 given HOLD rating. The consensus recommendation by Thomson Reuters analysts is -0.03 and their mean rating for the stock is 3.25on scale of 1-5. Analysts mean target price for Hecla Mining Company (NYSE:HL) is $2.02 while their mean recommendation is 3.20 (1=Buy, 5=sell). 

If we look at stock performance in last active day trading, we see that stock has moved fell -1.13% to end the day at $1.75. The current share price indicate that stock is -55.24% away from its one year high and is moving 44.63% ahead of its 52-week low. 

Leave a Reply